# Sulfasalazine in Patients With Metastatic Colorectal Cancer

> **NCT06134388** · PHASE3 · RECRUITING · sponsor: **Tanta University** · enrollment: 50 (estimated)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Sulfasalazine

## Key facts

- **NCT ID:** NCT06134388
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-01
- **Primary completion:** 2025-09
- **Final completion:** 2026-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06134388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06134388, "Sulfasalazine in Patients With Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06134388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*